Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells ‐based therapy product
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells
‐based
therapy product
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-18
DOI
10.1002/sctm.20-0242
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retinal Pigment Epithelium Replacement Therapy for Age-Related Macular Degeneration: Are We There Yet?
- (2020) Ruchi Sharma et al. Annual Review of Pharmacology and Toxicology
- Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs
- (2019) Ruchi Sharma et al. Science Translational Medicine
- A strategic road map to filing a Biologics License Application for a pluripotent stem cell derived therapeutic product
- (2019) Abla A. Creasey et al. BIOLOGICALS
- Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon
- (2019) Michael Mendicino et al. CYTOTHERAPY
- Automation in cell and gene therapy manufacturing: from past to future
- (2019) P. Moutsatsou et al. BIOTECHNOLOGY LETTERS
- Retinal stem cell transplantation: Balancing safety and potential
- (2019) Mandeep S. Singh et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Deep learning predicts function of live retinal pigment epithelium from quantitative microscopy
- (2019) Nicholas J. Schaub et al. JOURNAL OF CLINICAL INVESTIGATION
- Identifying cell populations with scRNASeq
- (2018) Tallulah S. Andrews et al. MOLECULAR ASPECTS OF MEDICINE
- Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
- (2017) Florian T. Merkle et al. NATURE
- Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
- (2017) Michiko Mandai et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10 Questions: Clinical Outlook for iPSCs
- (2016) Cell Stem Cell
- Current perspectives on the use of ancillary materials for the manufacture of cellular therapies
- (2016) Jennifer Solomon et al. CYTOTHERAPY
- How iPS cells changed the world
- (2016) Megan Scudellari NATURE
- Induced pluripotent stem cell technology: a decade of progress
- (2016) Yanhong Shi et al. NATURE REVIEWS DRUG DISCOVERY
- Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders
- (2016) Aurelie Bedel et al. Stem Cells Translational Medicine
- Hurdles to clinical translation of human induced pluripotent stem cells
- (2015) Evgenios Neofytou et al. JOURNAL OF CLINICAL INVESTIGATION
- Current status of pluripotent stem cells: moving the first therapies to the clinic
- (2015) Erin A. Kimbrel et al. NATURE REVIEWS DRUG DISCOVERY
- The Economics of Reproducibility in Preclinical Research
- (2015) Leonard P. Freedman et al. PLOS BIOLOGY
- Concise Review: Making and Using Clinically Compliant Pluripotent Stem Cell Lines
- (2015) Melissa K. Carpenter et al. Stem Cells Translational Medicine
- cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
- (2015) Behnam Ahmadian Baghbaderani et al. Stem Cell Reports
- The immunogenicity of cells derived from induced pluripotent stem cells
- (2013) Xuemei Fu Cellular & Molecular Immunology
- Genomic Instability in Pluripotent Stem Cells: Implications for Clinical Applications
- (2013) Suzanne E. Peterson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
- (2013) Andrew S Lee et al. NATURE MEDICINE
- Assessing iPSC reprogramming methods for their suitability in translational medicine
- (2012) Mahendra S. Rao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Assessing the Risks of Genotoxicity in the Therapeutic Development of Induced Pluripotent Stem Cells
- (2012) So Gun Hong et al. MOLECULAR THERAPY
- Translation of Stem Cell Research: Points to Consider in Designing Preclinical Animal Studies
- (2012) Joyce Frey-Vasconcells et al. Stem Cells Translational Medicine
- Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development
- (2012) Janis Ancans Frontiers in Immunology
- Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency
- (2011) Frederick Anokye-Danso et al. Cell Stem Cell
- Small RNA-mediated regulation of iPS cell generation
- (2011) Zhonghan Li et al. EMBO JOURNAL
- Risk factors in the development of stem cell therapy
- (2011) Carla A Herberts et al. Journal of Translational Medicine
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Generation of Induced Pluripotent Stem Cells from CD34+ Cells across Blood Drawn from Multiple Donors with Non-Integrating Episomal Vectors
- (2011) Amanda A. Mack et al. PLoS One
- Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
- (2011) H. Ban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
- (2010) Luigi Warren et al. Cell Stem Cell
- Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification
- (2010) Raymond W. Nims et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors
- (2010) Kazim H Narsinh et al. Nature Protocols
- Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of Injection
- (2010) Ivan Gutierrez-Aranda et al. STEM CELLS
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
- (2009) Dohoon Kim et al. Cell Stem Cell
- Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
- (2009) Hongyan Zhou et al. Cell Stem Cell
- Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells
- (2009) Sarah Eminli et al. NATURE GENETICS
- Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
- (2009) J. Yu et al. SCIENCE
- Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies
- (2009) Hannes Hentze et al. Stem Cell Research
- Adenoviral Gene Delivery Can Reprogram Human Fibroblasts to Induced Pluripotent Stem Cells
- (2009) Wenbo Zhou et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More